By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    medicare part d benefits
    Everything that You Need to Know About Medicare Part D
    August 15, 2022
    Best Ways to Boost Your Immune System this Winter
    Best Ways to Boost Your Immune System this Winter
    November 15, 2022
    back pain issues
    Ways to Treat Constant Back Pain
    August 21, 2023
    Latest News
    How Probate Planning Shapes the Future of Your Estate and Family Care
    July 17, 2025
    Beyond Nutrition: Everyday Foods That Support Whole-Body Health
    June 15, 2025
    The Wide-Ranging Benefits of Magnesium Supplements
    June 11, 2025
    The Best Home Remedies for Migraines
    June 5, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    More On Wellness Programs To Improve Health and Reduce Costs
    January 25, 2012
    Privatizing Social Security and Medicare: Who Can Defuse Political Dynamite?
    June 12, 2011
    Study: Risk of Death in Elderly Patients with Dementia Doubled with Some Antipsychotic Medications
    February 26, 2012
    Latest News
    How IT and Marketing Teams Can Collaborate to Protect Patient Trust
    July 17, 2025
    How Health Choices and Legal Actions Intersect After an Injury
    July 17, 2025
    How communities and healthcare providers can address slip and fall injuries with legal awareness
    July 17, 2025
    Let Your Lawyer Handle the Work Before You Pay Medical Costs
    July 6, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Observations on the PSA Testing Debate
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Diagnostics > Observations on the PSA Testing Debate
DiagnosticsPolicy & Law

Observations on the PSA Testing Debate

DavidEWilliams
DavidEWilliams
Share
6 Min Read
SHARE

Much has and will be written on the new US Preventive Services Task Force (USPTF) recommendations against routine use of the prostate specific antigen (PSA) blood test in healthy men .

I’m not a doctor or scientist and have not had the PSA test or a subsequent biopsy myself, but I am a close observer of the health care system. Two key takeaways for me are:

Much has and will be written on the new US Preventive Services Task Force (USPTF) recommendations against routine use of the prostate specific antigen (PSA) blood test in healthy men .

I’m not a doctor or scientist and have not had the PSA test or a subsequent biopsy myself, but I am a close observer of the health care system. Two key takeaways for me are:

More Read

workers comp ICD10 his
Workers’ Compensation and ICD-10
Memorial Sloan-Kettering Says No to Cancer Drug Zaltrap for Colorectal Cancer-Avastin Works Just As Well and the Cost is Half
Seven Senior Health Tips For The Holidays
Clinics, Free Clinics, and the Future Uninsured – Interview with Erika Viccellio
Massachusetts Governor’s Race: Views on Healthcare
  • The USPTF should have issued the PSA guidelines before it issued the screening mammography guidelines
  • A substantial, positive effect of the new guidelines will be to empower patients and families to take a more active role in their care, which will counterbalance some of the bias toward unnecessary treatment that currently characterizes the system

Let me explain:

It appears the USPTF put off the PSA decision after the firestorm of criticism ignited by its 2009 recommendation to reduce the use of screening mammography on younger women. In my estimation the leading reason for all the fuss two years ago was that while it was easy to identify people whose lives may have been saved by screening mammography, it was harder –though far from impossible—to identify people who’d been harmed. In addition, a whole movement had been built through the joint efforts of patient activists and commercial interests, with increases in screening mammography rates held up as an explicit goal. And finally, the issue of breast cancer is inextricably connected with the empowerment of women and access to the health care system.

PSA screening is different. No one thinks PSA is a great test: the high rates of false positives and false negatives are widely acknowledged. Watchful waiting is an accepted practice. Many patients understand that treatment involves serious tradeoffs, especially the strong possibility of incontinence and impotence. People are learning that biopsies have their own challenges, such as the possibility of blood in the semen for weeks afterwards. Many people who get prostate cancer die of something else.  Finally access to PSA testing is not connected with any male empowerment movement that I’m aware of.

If the Task Force had issued the PSA recommendation first it would have given people an opportunity to discuss and debate some of the central issues and nuances of screening without so many of the distractions. Maybe that would have cleared the way for a more thoughtful discourse on screening mammography.

I thought the New York Times did a great job of laying out the range of reactions in its letters section today:

  • An academic oncologist points out that the PSA blood test doesn’t cause impotence or incontinence and that 30,000 men die of prostate cancer in the US annually. His solution: use the test, but carefully, and have doctor and patient work together to decide course of action. I agree.
  • The wife of a man treated for prostate cancer points out the “terrible toll” of treatments and says the only benefit is to the medical/industrial complex. I generally agree, but she goes too far in ascribing PSA testing solely to financial interests.
  • An academic urologist argues its irresponsible to reject PSA based on 10 year follow-up data, when 20 years is more appropriate. He may have a point, but he neglects any mention of the harm of false positives.
  • A man who had a positive biopsy after his PSA spiked underwent radiation treatment and recovered with minimal side effects. He’s outraged by the recommendation to stop PSA. Hard to argue, and he should count himself among the lucky.
  • A urologist suggests “rationing” (his words) by banning Medicare from paying for screening of men over 75 or 80 when it pretty clearly does more harm than good. His letter is perhaps the best, and he is the only one of the writers who steps outside his own self-interest to make a broader point.

As people read this range of strongly held, but complementary views I feel confident many will be in a better position to make informed decisions in their particular situations.

 

 


TAGGED:cancerprostate cancerPSA
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
How IT and Marketing Teams Can Collaborate to Protect Patient Trust
Global Healthcare Policy & Law
July 17, 2025
paramedics in surgical gloves and masks
How Health Choices and Legal Actions Intersect After an Injury
Health care
July 16, 2025
a woman giving a key
How Probate Planning Shapes the Future of Your Estate and Family Care
Health
July 16, 2025
a woman with kinesio tapes on her back arm
How communities and healthcare providers can address slip and fall injuries with legal awareness
Health care
July 16, 2025

You Might also Like

The Power of Observational Studies

March 3, 2012

Cigarette Makers Sue the FDA Over New Labeling Rules

August 17, 2011
Covid-19Health care

How The Coronavirus Changed Healthcare For Patients And Medical Pros

May 11, 2020

Where is the Device Industry’s Seat at the “Network of Experts” Table?

December 9, 2011
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?